• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视觉前列腺症状评分与下尿路症状患者国际前列腺症状评分的相关性。

Correlation between the visual prostate symptom score and international prostate symptom score in patients with lower urinary tract symptoms.

机构信息

Department of Urology, National Police Hospital, Seoul, Korea.

出版信息

Int Neurourol J. 2014 Mar;18(1):37-41. doi: 10.5213/inj.2014.18.1.37. Epub 2014 Mar 31.

DOI:10.5213/inj.2014.18.1.37
PMID:24729926
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3983508/
Abstract

PURPOSE

To evaluate the correlation between the Visual Prostate Symptom Score (VPSS) and International Prostate Symptom Score (IPSS).

METHODS

We enrolled 240 new male patients who had visited National Police Hospital more than twice during a 6-month period starting from July 2013. At initial visit, the Korean version of the IPSS and VPSS, uroflowmetry, and transrectal ultrasonography were used to evaluate urinary symptoms. After medication, IPSS and VPSS questionnaires were issued again. The Spearman correlation test and the Mantel-Haenszel test were used to evaluate the relationship between the IPSS and VPSS.

RESULTS

The median age, total prostate volume, total IPSS, and total VPSS were 59.0 years, 28.0 mL, 12, and 9, respectively. Total VPSS, VPSS obstructive symptoms, VPSS irritative symptoms, and VPSS quality of life (QoL) significantly correlated with the total IPSS, IPSS obstructive symptoms, IPSS irritative symptoms, and IPSS QoL, respectively (correlation coefficient, P-value: 0.632, <0.001; 0.431, <0.001; 0.696, <0.001; and 0.799, <0.001; respectively). The change in the total IPSS after treatment also significantly correlated with the change in total VPSS after treatment (correlation coefficient, P-value: 0.364, <0.001). There were significant correlations between maximal flow rate and IPSS/VPSS obstructive symptoms (correlation coefficient, P-value: -0.190, 0.004; -0.269, <0.001, respectively). Additionally, there was a significant increase in the ratio of the maximal flow rate <15 mL/sec to VPSS obstructive symptoms as the severity of the VPSS obstructive symptoms increased (P trend <0.001).

CONCLUSIONS

VPSS might be useful in evaluating lower urinary tract symptoms at the initial visit and assessing these symptoms at longitudinal follow-up examinations.

摘要

目的

评估视觉前列腺症状评分(VPSS)与国际前列腺症状评分(IPSS)之间的相关性。

方法

我们招募了 240 名新的男性患者,他们在 2013 年 7 月开始的 6 个月期间内,至少两次到国立警察医院就诊。在初次就诊时,使用韩文版 IPSS 和 VPSS、尿流率测定和经直肠超声检查来评估尿路症状。用药后,再次发放 IPSS 和 VPSS 问卷。使用 Spearman 相关检验和 Mantel-Haenszel 检验来评估 IPSS 和 VPSS 之间的关系。

结果

中位年龄、总前列腺体积、总 IPSS 和总 VPSS 分别为 59.0 岁、28.0mL、12 和 9。总 VPSS、VPSS 梗阻症状、VPSS 刺激症状和 VPSS 生活质量(QoL)与总 IPSS、IPSS 梗阻症状、IPSS 刺激症状和 IPSS QoL 分别显著相关(相关系数,P 值:0.632,<0.001;0.431,<0.001;0.696,<0.001;0.799,<0.001)。治疗后总 IPSS 的变化也与治疗后总 VPSS 的变化显著相关(相关系数,P 值:0.364,<0.001)。最大尿流率与 IPSS/VPSS 梗阻症状之间存在显著相关性(相关系数,P 值:-0.190,0.004;-0.269,<0.001)。此外,随着 VPSS 梗阻症状的严重程度增加,最大尿流率<15mL/sec 与 VPSS 梗阻症状的比值显著增加(趋势 P <0.001)。

结论

VPSS 可能有助于在初始就诊时评估下尿路症状,并在纵向随访检查中评估这些症状。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa2/3983508/d1a2d8d417cb/inj-18-37-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa2/3983508/d1a2d8d417cb/inj-18-37-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa2/3983508/d1a2d8d417cb/inj-18-37-g001.jpg

相似文献

1
Correlation between the visual prostate symptom score and international prostate symptom score in patients with lower urinary tract symptoms.视觉前列腺症状评分与下尿路症状患者国际前列腺症状评分的相关性。
Int Neurourol J. 2014 Mar;18(1):37-41. doi: 10.5213/inj.2014.18.1.37. Epub 2014 Mar 31.
2
Comparison of Visual Prostate Symptom Score with the International Prostate Symptom Score and uroflowmetry parameters in assessing men with lower urinary tract symptoms in Dr. Cipto Mangunkusumo National General Hospital, Indonesia.在印度尼西亚西托·曼古库苏莫国家综合医院,比较视觉前列腺症状评分与国际前列腺症状评分及尿流率参数在评估下尿路症状男性中的应用。
Prostate Int. 2019 Sep;7(3):91-95. doi: 10.1016/j.prnil.2018.09.001. Epub 2018 Sep 25.
3
Comparison between visual prostate symptom score and international prostate symptom score in males older than 40 years in rural Indonesia.比较 40 岁以上印度尼西亚农村男性的视觉前列腺症状评分和国际前列腺症状评分。
Prostate Int. 2014 Dec;2(4):176-81. doi: 10.12954/PI.14059. Epub 2014 Aug 21.
4
Comparison of Visual Prostate Symptom Score and International Prostate Symptom Score in the evaluation of men with benign prostatic hyperplasia: A prospective study from an Indian population.在评估良性前列腺增生男性患者中视觉前列腺症状评分与国际前列腺症状评分的比较:一项来自印度人群的前瞻性研究。
Prostate Int. 2017 Dec;5(4):158-161. doi: 10.1016/j.prnil.2017.04.004. Epub 2017 Apr 22.
5
Study of correlation between Visual Prostate Symptom Score and International Prostate Symptom Score in men with lower urinary tract symptoms with reference to Uroflowmetry parameters in Indian population.印度人群下尿路症状患者的尿流率参数与视觉前列腺症状评分和国际前列腺症状评分的相关性研究。
Urologia. 2023 May;90(2):377-380. doi: 10.1177/03915603231157573. Epub 2023 Mar 8.
6
New Visual Prostate Symptom Score versus International Prostate Symptom Score in Men with Lower Urinary Tract Symptoms: A Prospective Comparision in Indian Rural Population.下尿路症状男性的新视觉前列腺症状评分与国际前列腺症状评分:印度农村人口的前瞻性比较
Niger J Surg. 2016 Jul-Dec;22(2):111-117. doi: 10.4103/1117-6806.189002.
7
[Validation of visual prostate symptom score, VPSS, in the evaluation of lower urinary tract symptoms associated with benign prostatic hyperplasia (550 patients)].[视觉前列腺症状评分(VPSS)在评估与良性前列腺增生相关的下尿路症状中的验证(550例患者)]
Prog Urol. 2017 Mar;27(3):176-183. doi: 10.1016/j.purol.2017.01.002. Epub 2017 Mar 9.
8
Prospective comparison of the novel visual prostate symptom score (VPSS) versus the international prostate symptom score (IPSS), and assessment of patient pain perception with regard to transrectal ultrasound guided prostate biopsy.前瞻性比较新型视觉前列腺症状评分(VPSS)与国际前列腺症状评分(IPSS),并评估经直肠超声引导下前列腺活检患者的疼痛感知。
Int Braz J Urol. 2019 Jan-Feb;45(1):137-144. doi: 10.1590/S1677-5538.IBJU.2018.0496.
9
Is new visual prostate symptom score useful as International Prostate Symptom Score in the evaluation of men with lower urinary tract symptoms? A prospective comparison of 2 symptom scores in Turkish society.在评估男性下尿路症状时,新的视觉前列腺症状评分作为国际前列腺症状评分是否有用?土耳其社会中两种症状评分的前瞻性比较。
Urology. 2015 Mar;85(3):653-7. doi: 10.1016/j.urology.2014.10.057.
10
To investigate the correlation between the visual prostate symptom score, the international prostate symptom score, and uroflowmetry parameters in adult Thai males of different educational levels.调查不同教育水平的成年泰国男性的视觉前列腺症状评分、国际前列腺症状评分与尿流率参数之间的相关性。
Prostate Int. 2018 Sep;6(3):115-118. doi: 10.1016/j.prnil.2017.12.001. Epub 2017 Dec 30.

引用本文的文献

1
Correlation between Uroflowmetry and International Prostate Symptoms Score in the evaluation of Nigerian men with Benign Prostatic Enlargement.尿流率测定与国际前列腺症状评分在尼日利亚良性前列腺增生男性评估中的相关性
Niger Med J. 2022 May 13;62(5):219-225. doi: 10.60787/NMJ-62-5-44. eCollection 2021 Sep-Oct.
2
How Do Patients Understand Questions about Lower Urinary Tract Symptoms? A Qualitative Study of Problems in Completing Urological Questionnaires.患者如何理解下尿路症状相关问题?一项关于完成泌尿科问卷时存在问题的定性研究。
Int J Environ Res Public Health. 2022 Aug 5;19(15):9650. doi: 10.3390/ijerph19159650.
3

本文引用的文献

1
Prospective evaluation of a new visual prostate symptom score, the international prostate symptom score, and uroflowmetry in men with urethral stricture disease.前瞻性评估新的视觉前列腺症状评分、国际前列腺症状评分和尿流率测定在尿道狭窄疾病男性中的应用。
Urology. 2014 Jan;83(1):220-4. doi: 10.1016/j.urology.2013.08.058. Epub 2013 Nov 11.
2
Prevalence of Benign Prostatic Hyperplasia on Jeju Island: Analysis from a Cross-sectional Community-based Survey.济州岛良性前列腺增生症的流行情况:一项基于社区的横断面调查分析。
World J Mens Health. 2012 Aug;30(2):131-7. doi: 10.5534/wjmh.2012.30.2.131. Epub 2012 Aug 31.
3
Prospective comparison of a new visual prostate symptom score versus the international prostate symptom score in men with lower urinary tract symptoms.
Effect of the whole seamless connection of nursing from WeChat interactive platform on stigma and quality of life in patients with urinary system cancer.
微信互动平台护理全程无缝衔接对泌尿系统癌症患者耻辱感及生活质量的影响
Digit Health. 2022 May 26;8:20552076221102772. doi: 10.1177/20552076221102772. eCollection 2022 Jan-Dec.
4
Visual Analogue Score for Urinary Symptoms-VASUS, validation of a visual scale for lower urinary tract symptoms (LUTS) in an African country.视觉模拟评分法用于下尿路症状(VASUS)——在非洲国家验证一种用于下尿路症状(LUTS)的视觉量表。
World J Urol. 2021 Nov;39(11):4191-4197. doi: 10.1007/s00345-021-03730-5. Epub 2021 May 18.
5
Can new, improvised Visual Prostate Symptom Score replace the International Prostate Symptom Score? Indian perspective.新型简易视觉前列腺症状评分能否取代国际前列腺症状评分?印度视角。
Indian J Urol. 2020 Apr-Jun;36(2):123-129. doi: 10.4103/iju.IJU_300_19. Epub 2020 Apr 7.
6
A simplified Italian translation of the international prostate symptom score twists the reality in the aging male with lower urinary tract symptoms.国际前列腺症状评分的简化意大利语翻译歪曲了老年男性下尿路症状的实际情况。
Prostate Cancer Prostatic Dis. 2020 Sep;23(3):534-536. doi: 10.1038/s41391-020-0203-9. Epub 2020 Jan 13.
7
Comparison of Visual Prostate Symptom Score with the International Prostate Symptom Score and uroflowmetry parameters in assessing men with lower urinary tract symptoms in Dr. Cipto Mangunkusumo National General Hospital, Indonesia.在印度尼西亚西托·曼古库苏莫国家综合医院,比较视觉前列腺症状评分与国际前列腺症状评分及尿流率参数在评估下尿路症状男性中的应用。
Prostate Int. 2019 Sep;7(3):91-95. doi: 10.1016/j.prnil.2018.09.001. Epub 2018 Sep 25.
8
To investigate the correlation between the visual prostate symptom score, the international prostate symptom score, and uroflowmetry parameters in adult Thai males of different educational levels.调查不同教育水平的成年泰国男性的视觉前列腺症状评分、国际前列腺症状评分与尿流率参数之间的相关性。
Prostate Int. 2018 Sep;6(3):115-118. doi: 10.1016/j.prnil.2017.12.001. Epub 2017 Dec 30.
9
Comparison of Visual Prostate Symptom Score and International Prostate Symptom Score in the evaluation of men with benign prostatic hyperplasia: A prospective study from an Indian population.在评估良性前列腺增生男性患者中视觉前列腺症状评分与国际前列腺症状评分的比较:一项来自印度人群的前瞻性研究。
Prostate Int. 2017 Dec;5(4):158-161. doi: 10.1016/j.prnil.2017.04.004. Epub 2017 Apr 22.
10
Critical analysis of the literature investigating urogenital function preservation following robotic rectal cancer surgery.对机器人直肠癌手术后泌尿生殖功能保留相关文献的批判性分析。
World J Gastrointest Surg. 2016 Nov 27;8(11):744-754. doi: 10.4240/wjgs.v8.i11.744.
新视觉前列腺症状评分与国际前列腺症状评分在下尿路症状男性中的前瞻性比较。
Urology. 2011 Jul;78(1):17-20. doi: 10.1016/j.urology.2011.01.065. Epub 2011 May 7.
4
Update on AUA guideline on the management of benign prostatic hyperplasia.美国泌尿外科学会良性前列腺增生管理指南更新。
J Urol. 2011 May;185(5):1793-803. doi: 10.1016/j.juro.2011.01.074. Epub 2011 Mar 21.
5
One-year follow-up of 2829 patients with moderate to severe lower urinary tract symptoms treated with alfuzosin in general practice according to IPSS and a health-related quality-of-life questionnaire. BPM Group in General Practice.
Urology. 2000 Apr;55(4):540-6. doi: 10.1016/s0090-4295(99)00539-7.
6
Using repeated measures of symptom score, uroflowmetry and prostate specific antigen in the clinical management of prostate disease. Benign Prostatic Hyperplasia Treatment Outcomes Study Group.
J Urol. 1995 Jan;153(1):99-103. doi: 10.1097/00005392-199501000-00036.